Grant: Discovery Grants Program - Individual
University of Calgary
$48,000.00
Mechanisms of neurovascular coupling in humans
FY 2023-24
Summary
Background: The brain requires precise control of blood flow to ensure that appropriate energy is provided and waste is removed. The need for exceptionally controlled regulation in the brain is primarily due to the limited capacity for energy storage and high metabolic demand in this tissue. Neurovascular coupling (NVC) is thought to be a key mechanism regulating this control and describes the close temporal and regional linkage between neuronal activity and cerebral blood flow (CBF) responses. The neurovascular unit is well-equipped to control blood flow precisely, which is accomplished by the close interaction of three major components: 1) Vascular contractile cells; 2) The endothelium; 3) The neuron; and 4) The astrocyte.Importance: Unraveling the mechanisms of NVC is important to understanding fundamental central nervous system processes such as thought itself and how cognition changes over the human lifespan. Rationale: Much of the research into the mechanisms of NVC has been completed using animal models with anesthesia that impacts CBF regulation, or ex vivo models where important inputs to NVC may be disconnected (e.g., central sympathetic nervous system input). Furthermore, interspecies differences, particularly in terms of brain function, have been uncovered. These issues obviate clear understanding of NVC. Nonetheless, animal work shows that important components of the NVC cascade may be: 1) Nitric oxide production (a potent vasoactive substance) through nitric oxide synthase (NOS); and 2) Specific cell receptors (alpha1 and beta). These findings in animals form the starting point for my NVC research program using an in vivo un-anesthetized human model. Overall Goals: A) To advance our knowledge of NVC using novel interventions and research approaches, B) Produce technology improving the ease/quality of NVC assessments (e.g., novel software/hardware); C) Train the next generation of natural science/engineering HQP. Discovery Themes: 1) Delineate the role of NOS in NVC; 2) Understand the impact of alpha1 adrenergic receptors inNVC; 3) Reveal the influence of beta adrenergic receptors in NVC.Nature of Work: Using pharmacological and dietary interventions we will systematically inhibit and promote the NOS, alpha1 and beta pathways in 24 humans and evaluate the impact of these pathways on NVC. This will require 15 studies (312 assessments), taking place over 5 years.
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2018-03771
Name nom
Phillips, Aaron
Department département
Physiology and Pharmacology
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2018
Award amount
48000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Not available
Research subject en
Non disponible
Research subject fr
Non disponible
Application title
Mechanisms of neurovascular coupling in humans
Keyword
blood flow dynamics; cerebral blood flow regulation; cerebrovascular human physiology; functional hyperemia; neurovascular coupling
Application summary
Background: The brain requires precise control of blood flow to ensure that appropriate energy is provided and waste is removed. The need for exceptionally controlled regulation in the brain is primarily due to the limited capacity for energy storage and high metabolic demand in this tissue. Neurovascular coupling (NVC) is thought to be a key mechanism regulating this control and describes the close temporal and regional linkage between neuronal activity and cerebral blood flow (CBF) responses. The neurovascular unit is well-equipped to control blood flow precisely, which is accomplished by the close interaction of three major components: 1) Vascular contractile cells; 2) The endothelium; 3) The neuron; and 4) The astrocyte.Importance: Unraveling the mechanisms of NVC is important to understanding fundamental central nervous system processes such as thought itself and how cognition changes over the human lifespan. Rationale: Much of the research into the mechanisms of NVC has been completed using animal models with anesthesia that impacts CBF regulation, or ex vivo models where important inputs to NVC may be disconnected (e.g., central sympathetic nervous system input). Furthermore, interspecies differences, particularly in terms of brain function, have been uncovered. These issues obviate clear understanding of NVC. Nonetheless, animal work shows that important components of the NVC cascade may be: 1) Nitric oxide production (a potent vasoactive substance) through nitric oxide synthase (NOS); and 2) Specific cell receptors (alpha1 and beta). These findings in animals form the starting point for my NVC research program using an in vivo un-anesthetized human model. Overall Goals: A) To advance our knowledge of NVC using novel interventions and research approaches, B) Produce technology improving the ease/quality of NVC assessments (e.g., novel software/hardware); C) Train the next generation of natural science/engineering HQP. Discovery Themes: 1) Delineate the role of NOS in NVC; 2) Understand the impact of alpha1 adrenergic receptors inNVC; 3) Reveal the influence of beta adrenergic receptors in NVC.Nature of Work: Using pharmacological and dietary interventions we will systematically inhibit and promote the NOS, alpha1 and beta pathways in 24 humans and evaluate the impact of these pathways on NVC. This will require 15 studies (312 assessments), taking place over 5 years.